Abstract
Objective
The Joint Effort Initiative (JEI) is an international collaboration of clinicians, researchers, and consumer organisations with a shared vision of improving the implementation of osteoarthritis management programs (OAMPs). This study aimed to identify JEI's future priorities and guide direction.
Design
A two-part international survey to prioritise topics of importance to our membership and research stakeholders. Survey one presented a list of 40 topics under 5 themes. Consenting participants were asked to choose their top three topics in each theme. A short list of 25 topics was presented in survey two. Participants were asked to rank the importance (100-point NRS scale, 100 = highest priority). Response frequency (median, IQR) was used to rank the top priorities by theme.
Results
Ninety-five participants completed survey one (61% female, 48% clinicians) and 57 completed survey two. The top ranked topic/s were: i. Promotion and advocacy: support training for health professionals (median 85, IQR 24). ii. Education and training: incorporating behaviour change into OAMPs (80, 16), advanced OA skills (80, 30), and integration of OA education into clinical training (80, 36). iii. Improving OAMPs delivery: regular updates on changes to best-evidence OA care (84, 24). iv. Future research: improve uptake of exercise, physical activity, and weight-loss (89, 16). v. Enhancing relationships, alliances, and shared knowledge: promote research collaborations (81, 30), share challenges and opportunities for OAMP implementation (80, 23).
Conclusions
These topics will set the JEI's research and collaboration agenda for the next 5 years and stimulate ideas for others working in the field.
| Original language | English |
|---|---|
| Article number | 100408 |
| Number of pages | 10 |
| Journal | Osteoarthritis and Cartilage Open |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Dec 2023 |
Funding
We wish to acknowledge the support of the Osteoarthritis Research Society International (OARSI), OA Foundation International (OAFi), USA Arthritis Foundation, and the Osteoarthritis Action Alliance (OAAA). We also wish to acknowledge the funding bodies who have supported other work by the JEI, including the Australian Government Department of Health Public Health and Chronic Disease Program for Arthritis, Pfizer Global Medical Grants, and Pfizer Awards for Advancing Chronic Pain Research. There has been no funding provided for this study. JLB is partially supported by the Outcomes Measures in Rheumatology (OMERACT) scientific organisation. JPE is supported by a Sydney Health Partners Research Translation Fellowship. DJH is supported by an National Health and Medical Research Council (NHMRC Investigator Grant Leadership 2 (#1194737). RSH is supported by an National Health and Medical Research Council Senior Research Fellowship (#1154217). KLB is supported by a NHMRC Investigator Grant (#1174431). KSD is part funded by the National Institute for Health and Care Research (NIHR) Applied Health Research Collaboration (ARC) West Midlands (NIHR 200165). KD was also part funded by an NIHR Knowledge Mobilisation Research Fellowship (KMRF-2014-03-002) and is an NIHR Senior Investigator (ID NIHR 2000259). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.